SEARCH

SEARCH BY CITATION

References

  • Abe K., Takayanagi M. and Saito H. (1990) Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain. Jpn. J. Pharmacol. 53, 221227.
  • Aggarwal B. B., Kumar A. and Bharti A. C. (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363398.
  • Aoki H., Takada Y., Kondo S., Sawaya R., Aggarwal B. B. and Kondo Y. (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol. 72, 2939.
  • Barten D. M., Meredith J. E. Jr, Zaczek R., Houston J. G. and Albright C. F. (2006) Gamma-secretase inhibitors for Alzheimer’s disease: balancing efficacy and toxicity. Drugs Res. Dev. 7, 8797.
  • Behl C., Davis J. B., Lesley R. and Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817827.
  • Berger C., Schabitz W. R., Wolf M., Mueller H., Sommer C. and Schwab S. (2004) Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp. Neurol. 185, 305312.
  • Chen J., Zacharek A., Zhang C., Jiang H., Li Y., Roberts C., Lu M., Kapke A. and Chopp M. (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J. Neurosci. 25, 23662375.
  • Cole G. M., Teter B. and Frautschy S. A. (2007) Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 595, 197212.
  • Corson T. W. and Crews C. M. (2007) Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130, 769774.
  • Davis J. B. and Maher P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169173.
  • Frautschy S. A., Hu W., Kim P., Miller S. A., Chu T., Harris-White M. E. and Cole G. M. (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging 22, 9931005.
  • Goodman Y., Steiner M. R., Steiner S. M. and Mattson M. P. (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid [beta]-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654, 171176.
  • Harvey A. L. (1999) Medicines from nature: are natural products still relevant to drug discovery? Trends Pharmacol. Sci. 20, 196198.
  • Kang J. H., Kondo F. and Katayama Y. (2006) Human exposure to bisphenol A. Toxicology 226, 7989.
  • Keller C., Bruelisauer A., Lemaire M. and Enz A. (2002) Brain pharmacokinetics of a nonpeptidic corticotropin-releasing factor receptor antagonist. Drug Metab. Dispos. 30, 173176.
  • Kim H., Park B. S., Lee K. G., Choi C. Y., Jang S. S., Kim Y. H. and Lee S. E. (2005) Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J. Agric. Food Chem. 53, 85378541.
  • Koehn F. E. and Carter G. T. (2005) The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4, 206220.
  • Kurozumi K., Nakamura K., Tamiya T. et al. (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther. 11, 96104.
  • LaFerla F. M., Green K. N. and Oddo S. (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat. Rev. Neurosci. 8, 499509.
  • Lansbury P. T. and Lashuel H. A. (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774779.
  • Van Leyen K., Kim H. Y., Lee S. R., Jin G., Arai K. and Lo E. H.(2006) Baicalein and 12/15-Lipoxygenase in the Ischemic Brain. Stroke 37, 30143018, 2006 Oct 19; [E-Pub ahead of print].
  • Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A. and Cole G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 83708377.
  • Liu Y. and Schubert D. (1998) Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity. J. Neurochem. 71, 23222329.
  • Liu Y., Peterson D. A. and Schubert D. (1998) Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl Acad. Sci. USA 95, 1326613271.
  • Maezawa I., Hong H. S., Wu H. C. et al. (2006) A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J. Neurochem. 98, 5767.
  • Maher P. (2006) Redox control of neural functions: background, mechanisms and significance. Antioxid. Redox Signal. 8, 19411970.
  • Mattson M. P. and Cheng A. (2006) Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 29, 632639.
  • McPhie D. L., Lee R. K., Eckman C. B., Olstein D. H., Durham S. P., Yager D., Younkin S. G., Wurtman R. J. and Neve R. L. (1997) Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains. J. Biol. Chem. 272, 2474324746.
  • Molina-Holgado F., Hider R. C., Gaeta A., Williams R. and Francis P. (2007) Metals ions and neurodegeneration. Biometals 20, 639654.
  • Olney J. W. (1986) Inciting excitotoxic cytocide among central neurons, in Advances in Experimental Medicine and Biology (SchwarczR. and Ben-AriY., eds), pp. 632645. Plenum Press, New York.
  • Pangalos M. N., Schechter L. E. and Hurko O. (2007) Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat. Rev. Drug Discov. 6, 521532.
  • Paterson I. and Anderson E. A. (2005) The renaissance of natural products as drug candidates. Science 310, 451453.
  • Pezet S. and Malcangio M. (2004) Brain-derived neurotrophic factor as a drug target for CNS disorders. Exp. Opin. Ther. Targets 8, 391399.
  • Reinke A. A. and Gestwicki J. E. (2007) Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des. 70, 206215.
  • Rice-Evans C. and Miller N. J. (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol. 234, 279293.
  • Rice-Evans C. A., Miller N. J. and Paganga G. (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20, 933956.
  • Rossler O. G., Giehl K. M. and Thiel G. (2004) Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase. J. Neurochem. 88, 12401252.
  • Rothman S. M. (1985) The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J. Neurosci. 5, 14831489.
  • Rothman S. M. and Olney J. W. (1986) Glutamate and the pathophysiology of hypoxic – ischemic brain damage. Ann. Neurol. 19, 105111.
  • Scatena R., Martorana G. E., Bottoni P., Botta G., Pastore P. and Giardina B. (2007) An update on pharmacological approaches to neurodegenerative diseases. Exp. Opin. Invest. Drugs 16, 5972.
  • Schubert D. R. and Liu Y. (2002) Method for preventing and/or decreasing amyloid production with polycyclic compounds. US Patent No. 6,472,436B1.
  • Schubert D. and Piasecki D. (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 21, 74557462.
  • Sharma R. A., Steward W. P. and Gescher A. J. (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 595, 453470.
  • Sopher B. L., Fukuchi K., Smith A. C., Leppig K. A., Furlong C. E. and Martin G. M. (1994) Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res. Mol. Brain Res. 26, 207217.
  • Tan S., Schubert D. and Maher P. (2001) Oxytosis: a novel form of programmed cell death. Curr. Topics Med. Chem. 1, 497506.
  • Warren R. E. and Frier B. M. (2005) Hypoglycaemia and cognitive function. Diabetes Obes Metab. 7, 493503.
  • Woltjer R. L., Nghiem W., Maezawa I., Milatovic D., Vaisar T., Montine K. S. and Montine T. J. (2005) Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J. Neurochem. 93, 10471056.
  • Yang F., Lim G. P., Begum A. N. et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 58925901.
  • Yankner B. A., Duffy L. K. and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279282.